ADMA Biologics Inc at JPMorgan Healthcare Conference Transcript
Good morning, everyone. We're excited to be continuing our 44th Annual JPMorgan Healthcare Conference. My name is Roland Ye, and I'm associate on the Healthcare Investment Banking team here at JPMorgan. Today, it's my pleasure to introduce ADMA Biologics and its Founder, President and CEO, Adam Grossman. We'll have time for Q&A at the end.
And with that, I'll turn it over to Adam.
Thank you very much, Roland. Thank you very much to the entire JPMorgan Healthcare Banking team for the invitation. We are a public company. We trade under the symbol ADMA on the NASDAQ. Please refer to our forward-looking statements and other disclosures on our website and in our Form 10-K and 10-Q filings. So who we are? ADMA is a specialty producer of unique plasma-derived biologic products.
We mainly produce IVIG products, which are basically extracting all of the antibodies out of human plasma. We have three FDA-approved commercial
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
